Medication info

Nobelzin Capsule 25mg (Zinc Acetate)

Prescription medicationExpired
Ingredient · strength
Zinc Acetate Hydrate›Strength being verified
Manufacturer / importer
Hyundai Pharm Co., Ltd.
Appearance
Opaque blue capsule
Packaging
100 capsules/bottle
Approval status
Expired

MFDS item code 200906022 · Approved 2009.07.30

This product's status changed to Expired on 2023.07.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of Wilson's disease
Who uses it
Adults · Children
Adult dosage
Adults: The usual dose is 50mg of zinc per dose, administered orally 3 times daily. The maximum dose of this medicine is 250mg per day (50mg per dose, administered 5 times daily). For pregnant women, the usual dose is 25mg of zinc per dose, administered orally 3 times daily. For initial treatment of patients with symptomatic Wilson's disease, a chelating agent may be used, or a chelating agent may be used in combination with this medicine. This medicine may be used alone for initial treatment of patients with asymptomatic Wilson's disease. When this medicine is administered in combination with a chelating agent, allow an interval of at least 1 hour between doses. Administer orally at least 1 hour before a meal or at least 2 hours after a meal. When changing the dose, adjust it according to urinary copper excretion and urinary zinc excretion. Carefully change the dose with reference to the following table. If this medicine is continued, regularly assess changes in the patient's symptoms. Item Reference value 24-hour urinary copper excretion 0.05-0.125mg/day 24-hour urinary zinc excretion 2.0mg/day
Children's dosage
Children aged 6 years and older: The usual dose is 25mg of zinc per dose, administered orally 3 times daily.

Ingredients

Importer
Hyundai Pharm Co., Ltd.

Efficacy & effects

Treatment of Wilson's disease

  • Wilson's disease
View approved original text

Wilson's disease is a condition caused by excessive accumulation of copper in the body, primarily affecting the liver and nervous system. This medication is used to reduce copper accumulation in Wilson's disease, protecting liver function and alleviating neurological symptoms.

Dosage and Administration

Adult dosage

Adults: The usual dose is 50mg of zinc per dose, administered orally 3 times daily. The maximum dose of this medicine is 250mg per day (50mg per dose, administered 5 times daily). For pregnant women, the usual dose is 25mg of zinc per dose, administered orally 3 times daily. For initial treatment of patients with symptomatic Wilson's disease, a chelating agent may be used, or a chelating agent may be used in combination with this medicine. This medicine may be used alone for initial treatment of patients with asymptomatic Wilson's disease. When this medicine is administered in combination with a chelating agent, allow an interval of at least 1 hour between doses. Administer orally at least 1 hour before a meal or at least 2 hours after a meal. When changing the dose, adjust it according to urinary copper excretion and urinary zinc excretion. Carefully change the dose with reference to the following table. If this medicine is continued, regularly assess changes in the patient's symptoms. Item Reference value 24-hour urinary copper excretion 0.05-0.125mg/day 24-hour urinary zinc excretion 2.0mg/day

Children's dosage

Children aged 6 years and older: The usual dose is 25mg of zinc per dose, administered orally 3 times daily.

Precautions

This medication has a slow onset of action and is not suitable as an initial treatment for patients with symptoms; other treatments should be used first when symptoms are present. Patients allergic to this drug or its components should not use it. Use with caution in elderly patients, pregnant or breastfeeding women, children, and patients with non-specific liver disease. While using this medication, there may be increases in blood lipase and amylase levels, and caution is advised as symptoms such as decreased iron levels, gastric discomfort, vomiting, and abdominal pain may occur. When using this medication for the first time, liver function tests and urinalysis should be performed monthly to monitor liver health. If amylase and lipase levels remain elevated for an extended period, additional testing for pancreatic function may be necessary. This medication may have reduced efficacy when taken with specific chelators, thus should be taken with at least a 1-hour interval. If taken with food, absorption of this medication may be delayed, so it is advisable to take it more than 1 hour before meals or 2 hours after meals. Elderly patients may have reduced bodily functions and should use this medication with additional caution. Pregnant women or those of childbearing age should use this medication carefully, as there is limited experience with its use, and rare cases of fetal abnormalities have been reported. Breastfeeding women should avoid breastfeeding while using this medication, as it can be transferred into breast milk and may affect the baby's health. The safety of this medication in children or newborns, especially low birth weight newborns, is not well established and requires caution. Overdosing on this medication can lead to severe vomiting, dizziness, kidney damage, pancreatitis, and other serious side effects. In case of overdose, immediate measures such as gastric lavage or inducing vomiting should be taken, and specialized treatment should be sought if necessary.

Side effects

  • Increased serum lipase
  • increased serum amylase
  • decreased serum iron concentration
  • gastric discomfort
  • decreased serum total cholesterol
  • positive urinary hematuria
  • increased serum ALT (GPT)
  • leukopenia
  • positive urinary protein
  • decreased albumin
Show 22 more
  • nausea
  • vomiting
  • abdominal pain
  • diarrhea
  • stomatitis
  • hepatomegaly
  • cystitis
  • miliary tuberculosis
  • headache
  • iron deficiency during menstruation
  • weight loss
  • multiple sclerosis
  • syncope
  • viral infection
  • tremor
  • esophageal variceal bleeding
  • uterine rupture
  • miscarriage
  • immobile dizziness
  • renal failure
  • hyperglycemic coma
  • hemorrhagic pancreatitis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be phot-sensitive and should be stored in a container that blocks light. Additionally, to avoid damage to the medication, it should be stored at room temperature, between 1°C to 30°C.

Appearance and packaging

Appearance

Opaque blue capsule

Package unit

100 capsules/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.